Allergan and SonarMD have partnered to develop clinical decision support and patient engagement tools to diagnose and manage patients with a form of irritable bowel syndrome.
By using this engagement platform, physicians will be able to monitor patients suffering from irritable bowel syndrome with diarrhea. The platform's services will include assessments of symptoms and treatment impact. Allergan and SonarMD say that the platform will also help to generate real-world data on the effects of various treatment options.
SonarMD has already developed a cloud-based care management platform for patients with other chronic illnesses, such as Crohn's disease. This platform was created by gastroenterologist Lawrence Kosinski, MD.